| ViraEpi1669 | Epstein barr virus (EBV) | LRS | NA | 169603 | 169603 | Hyper | 100% | Cell line | Rael cell line (BL type I) | 3-6 clones | Burkitt Lymphoma (BL) | Bisulfite seq | 9525618 | | ViraEpi1670 | Epstein barr virus (EBV) | LRS | NA | 169613 | 169613 | Hyper | 100% | Cell line | Rael cell line (BL type I) | 3-6 clones | Burkitt Lymphoma (BL) | Bisulfite seq | 9525618 | | ViraEpi1671 | Epstein barr virus (EBV) | LRS | NA | 169624 | 169624 | Hypo | > 20% and < 40% | Cell line | Rael cell line (BL type I) | 3-6 clones | Burkitt Lymphoma (BL) | Bisulfite seq | 9525618 | | ViraEpi1672 | Epstein barr virus (EBV) | LRS | NA | 169639 | 169639 | Hyper | 70% | Cell line | Rael cell line (BL type I) | 3-6 clones | Burkitt Lymphoma (BL) | Bisulfite seq | 9525618 | | ViraEpi1673 | Epstein barr virus (EBV) | LRS | NA | 169645 | 169645 | Hyper | 100% | Cell line | Rael cell line (BL type I) | 3-6 clones | Burkitt Lymphoma (BL) | Bisulfite seq | 9525618 | | ViraEpi1674 | Epstein barr virus (EBV) | LRS | NA | 169648 | 169648 | Hyper | 100% | Cell line | Rael cell line (BL type I) | 3-6 clones | Burkitt Lymphoma (BL) | Bisulfite seq | 9525618 | | ViraEpi1675 | Epstein barr virus (EBV) | LRS | NA | 169669 | 169669 | Hyper | 80% | Cell line | Rael cell line (BL type I) | 3-6 clones | Burkitt Lymphoma (BL) | Bisulfite seq | 9525618 | | ViraEpi1676 | Epstein barr virus (EBV) | LRS | NA | 169691 | 169691 | Hyper | 80% | Cell line | Rael cell line (BL type I) | 3-6 clones | Burkitt Lymphoma (BL) | Bisulfite seq | 9525618 | | ViraEpi1677 | Epstein barr virus (EBV) | LRS | NA | 21A | 21A | Hyper | 80% | Cell line | Rael cell line (BL type I) | 3-6 clones | Burkitt Lymphoma (BL) | Bisulfite seq | 9525618 | | ViraEpi1678 | Epstein barr virus (EBV) | LRS | NA | 22 | 22 | Intermediate | > 40% and < 60% | Cell line | Rael cell line (BL type I) | 3-6 clones | Burkitt Lymphoma (BL) | Bisulfite seq | 9525618 | | ViraEpi1679 | Epstein barr virus (EBV) | LRS | NA | 23 | 23 | Hyper | 100% | Cell line | Rael cell line (BL type I) | 3-6 clones | Burkitt Lymphoma (BL) | Bisulfite seq | 9525618 | | ViraEpi1680 | Epstein barr virus (EBV) | LRS | NA | 24 | 24 | No methylation | 0% | Cell line | Rael cell line (BL type I) | 3-6 clones | Burkitt Lymphoma (BL) | Bisulfite seq | 9525618 | | ViraEpi1681 | Epstein barr virus (EBV) | LRS | NA | 25 | 25 | Hyper | 70% | Cell line | Rael cell line (BL type I) | 3-6 clones | Burkitt Lymphoma (BL) | Bisulfite seq | 9525618 | | ViraEpi1682 | Epstein barr virus (EBV) | LRS | NA | 26 | 26 | Hyper | 100% | Cell line | Rael cell line (BL type I) | 3-6 clones | Burkitt Lymphoma (BL) | Bisulfite seq | 9525618 | | ViraEpi1683 | Epstein barr virus (EBV) | LRS | NA | 27 | 27 | Hyper | 100% | Cell line | Rael cell line (BL type I) | 3-6 clones | Burkitt Lymphoma (BL) | Bisulfite seq | 9525618 | | ViraEpi1684 | Epstein barr virus (EBV) | LRS | NA | 27A | 27A | Hyper | 100% | Cell line | Rael cell line (BL type I) | 3-6 clones | Burkitt Lymphoma (BL) | Bisulfite seq | 9525618 | | ViraEpi1685 | Epstein barr virus (EBV) | LRS | NA | 28 | 28 | Hyper | 100% | Cell line | Rael cell line (BL type I) | 3-6 clones | Burkitt Lymphoma (BL) | Bisulfite seq | 9525618 | | ViraEpi1686 | Epstein barr virus (EBV) | LRS | NA | 29 | 29 | Hyper | 100% | Cell line | Rael cell line (BL type I) | 3-6 clones | Burkitt Lymphoma (BL) | Bisulfite seq | 9525618 | | ViraEpi1687 | Epstein barr virus (EBV) | LRS | NA | 30 | 30 | Hyper | 80% | Cell line | Rael cell line (BL type I) | 3-6 clones | Burkitt Lymphoma (BL) | Bisulfite seq | 9525618 |